Harbor BioSciences Statistics
Harbor BioSciences (HRBR) Stock Statistics & Valuation Metrics
Total Valuation
Harbor BioSciences has a market cap or net worth of $140.23M. The enterprise value is $90.78T.
- Market Cap
- $140.23M
- Enterprise Value
- $90.78T
Share Statistics
Harbor BioSciences has 58,429,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 58,429,836
- Owned by Insiders
- ―
- Owned by Institutions
- 0.03%
Financial Efficiency
Harbor BioSciences’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 0.00%
- Return on Capital Employed (ROCE)
- 0.00
- Revenue Per Employee
- 0
- Profits Per Employee
- 128.755
- Employee Count
- 233
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Harbor BioSciences is -8.57. Harbor BioSciences’s PEG ratio is -0.20.
- PE Ratio
- -8.57
- PS Ratio
- 21.98
- PB Ratio
- 0.89
- Price to FCF
- -3.15
- Price to Operating Cash Flow
- -3.15
- PEG Ratio
- -0.20
Income Statement
In the last 12 months, Harbor BioSciences had revenue of 0 and earned 30.00K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- 0
- Pretax Income
- 30.00K
- Net Income
- 30.00K
- EBITDA
- 0
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -32.30M and capital expenditures 0, giving a free cash flow of -32.30M billion.
- Operating Cash Flow
- -32.30M
- Free Cash Flow
- -32.30M
- Free Cash Flow per Share
- -0.77
Dividends & Yields
Harbor BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -31.73%
- Earnings Yield
- -11.63%
Stock Price Statistics
- Beta
- 19.04
- 52-Week Price Change
- 146.94%
- 50-Day Moving Average
- 2.26
- 200-Day Moving Average
- 1.84
- Relative Strength Index (RSI)
- 72.06
- Average Volume (3m)
- 11.34K
Financial Position
Harbor BioSciences as a current ratio of 0.00, with Debt / Equity ratio of 0.82%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.01
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Harbor BioSciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Harbor BioSciences EV to EBITDA ratio is -6.23, with an EV/FCF ratio of -2.96.
- EV to Sales
- 20.65
- EV to EBITDA
- -6.23
- EV to Free Cash Flow
- -2.96
- EV to Operating Cash Flow
- -2.96
Balance Sheet
Harbor BioSciences has $52.27M in cash and marketable securities with $5.58M in debt, giving a net cash position of $46.69M billion.
- Cash & Marketable Securities
- $52.27M
- Total Debt
- $5.58M
- Net Cash
- $46.69M
- Net Cash Per Share
- $0.80
- Tangible Book Value Per Share
- $2.63
Margins
Gross margin is -424.87%, with operating margin of -580.43%, and net profit margin of -255.69%.
- Gross Margin
- -424.87%
- Operating Margin
- -580.43%
- Pretax Margin
- -365.03%
- Net Profit Margin
- -255.69%
- EBITDA Margin
- -331.38%
- EBIT Margin
- -440.69%
Analyst Forecast
The average price target for Harbor BioSciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -67.05%
- EPS Growth Forecast
- ―
